Eugene Sefanov

  Now that March is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in February – they’re ranked in order of popularity, with number one being the most viewed piece. 

  Heavily regulated industries, such as financial services, are often slow to adopt new technology. That’s why it’s no surprise that social media is a scary place to play for financial institutions. But, as with most things in business, if you don’t play, you can’t win. 

  Patients who are being treated for diseases, such as cancer, often require multiple drugs to manage their conditions. For example, patients are often prescribed drugs that treat the actual disease, while others are meant to manage side effects from those drugs. Many of these patients can probably attest to inquiring about or doing their […]

  According to an article in Clinical Leader that featured Bayer Healthcare’s VP Global Strategy & Development Advisor, by evaluating certain criteria against patient populations, electronic health record (EHR) systems can help sponsors determine trial feasibility and shape better study protocols. This can reduce the number of amendments, which can cost anywhere from $300,000 to […]

  Not long ago, our team published a guide on Google Search for Life Sciences because the Google Search Appliance (GSA) can work wonders for companies in our industry. But we just learned that Google has decided to put that powerful yellow box, designed to sit on-premises, to bed. Let me say that again: Google […]

  It’s often said that “music heals.” While it may not cure disease, some nations are turning to music in an attempt to prevent it. Jamaica’s Ministry of Health produced a reggae music video that’s about Zika, a virus that is spread through mosquito bites. According to the Center for Disease Control (CDC), Zika is […]

  Let me preface: this is just me playing devil’s advocate. To be fair. To give a different perspective. There is an exorbitant amount of conversation going on about the sharing and publication of all clinical trial data, good or bad. The reason? To help others out. To advance science. To save lives. 

  Efficiency and compliance are two critical components in highly-regulated industries, especially when it comes to developing drugs and medical devices. Unfortunately, though, these are two areas in which many life sciences companies struggle and could significantly improve through IT solutions. 

  Gartner forecasts that the business intelligence (BI) and analytics market will increase 5.2% over last year, reaching $16.9 billion by the end of 2016. Ian Bertram, managing vice president at Gartner, believes “The shift to the modern BI and analytics platform has now reached a tipping point.” He urges the organizations that are lagging […]

  Recruiting subjects for clinical trials has been a longstanding challenge for pharmaceutical and research organizations. According to Dr. Steven Alberts, Chair of Medical Oncology with the Mayo Clinic, only 5% of cancer patients ever enroll in a trial. On top of that, only a fraction of all trials ever finish enrolling enough patients on […]

  A few weeks ago, an opinion piece was featured on the international public broadcaster Deutsche Welle’s website. In her article, the author shared the “unfair” standards by which pharmaceutical companies are frequently judged. 

  A little over a year ago, I wrote about AstraZeneca’s road to becoming a digital transformation leader. With CIO David Smoley at the helm, the pharmaceutical giant is known to have been an early adopter of many cloud solutions, including Box, Salesforce, and Microsoft Office 365. While Smoley’s cloud-first mentality has helped save a […]